Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AT-1965 |
Synonyms | |
Therapy Description |
AT-1965 activates a B-cell immune response, potentially leading to decreased tumor growth (Cancer Res (2018) 78 (13_Supplement): 4712). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AT-1965 | AT 1965|AT1965 | AT-1965 activates a B-cell immune response, potentially leading to decreased tumor growth (Cancer Res (2018) 78 (13_Supplement): 4712). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06234098 | Phase Ib/II | AT-1965 | Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors | Recruiting | USA | 0 |